4//SEC Filing
NATAN DAVID 4
Accession 0000921895-25-000652
CIK 0001130166other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 4:48 PM ET
Size
6.1 KB
Accession
0000921895-25-000652
Insider Transaction Report
Form 4
NATAN DAVID
Director
Transactions
- Award
Non-Qualified Stock Option (Right to Buy)
2025-02-26+700,000→ 700,000 totalExercise: $0.33From: 2025-02-26Exp: 2035-02-26→ Common Stock (700,000 underlying)
Footnotes (2)
- [F1]On February 26, 2025 (the "Grant Date"), the Reporting Person was granted 700,000 Non-Qualified Stock Options to purchased shares of common stock (the "Common Stock") of Cyclacel Pharmaceuticals, Inc. (the "Company") in consideration of his services as a director of the Company. The option grant became exercisable on the Grant Date.
- [F2]Includes shares of Common Stock previously reported in Table I of the Reporting Person's Form 4 filed on January 7, 2025, which were not issued by the Company and are being replaced with the option grant reported in this Form 4.
Documents
Issuer
Cyclacel Pharmaceuticals, Inc.
CIK 0001130166
Entity typeother
Related Parties
1- filerCIK 0001253108
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 4:48 PM ET
- Size
- 6.1 KB